It took little over 40 Opentrons robots to provide the majority of COVID-19 testing for the city of New York - 15 million people. Top-tier investors have piled in, will their bets pay off in 2025?
Lexicon has been discovering new genetic science since the Human Genome Project. They've retained investor interest, and have 2 solid new FDA approvals. Dr. Mike Exton, with over 2 decades of pharma experience, was drafted in this Summer and has plans to make history... in 2025 Lexicon is
What happens when the medical ethics of ancient Greece cross paths with the pioneering developments of modern science?
We will publish our in-depth healthcare report, Vital Signs, in Fortune magazine on December 1, 2024. Vital Signs: Future of Healthcare will appear in Fortune ahead of one of the most important events in the industry: JPM Week, the annual healthcare conference hosted by J.P. Morgan at the Westin
GLP-1 is quickly becoming one of the most famous hormones in the world.
Genomics is seeing its golden age in the clinic. How did we get here?
How do they work, and how big is the market?
The must-read guide to one of the most anticipated periods of the year for professionals in biotech, pharma, and life sciences.
We expect the attendance for each to be well over 20,000 in 2025.
Over the past few years, cell and gene therapy have made enormous strides, offering hope to patients with diseases with no treatment.
If left untreated, Stargardt disease and Geographic Atrophy almost always lead to vision loss and blindness - but a groundbreaking oral treatment in the last stage of clinical trials offers new hope.
